Harvard Bioscience: Bouncing Higher From Multiple-Year SupportI zoomed all the way out to the monthly chart to show the long-term support levels. We can see that HBIO is bouncing higher from a multi-year support level in the $2 range. The MACD (middle of the chart) didn't confirm an upward trend yet. However, the MACD did confirm the upward trend on the weekly chart. It looks like the blue monthly MACD line is close to crossing above the red signal line. The purple RSI line on the bottom of the chart is pointing upward, which is bullish. This indicates that we could see a long-term continuation of the rally which began in December/January. Click on the link below for a detailed article. HBIO has a low valuation with strong expected EPS growth. This is likely to drive the stock higher IMO.
HBIO
Harvard Biosciences is struggling. HBIOWe are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in green with invalidation in red. Fibonacci goals, it is prudent to suggest, are nothing more than mere fractally evident and therefore statistically likely levels that the market will go to. Having said that, the market will always do what it wants and always has a mind of its own. Therefore, none of this is financial advice, so do your own research and rely only on your own analysis. Trading is a true one man sport. Good luck out there and stay safe
HBIO Bull Case Breaking through the double top barrier, HBIO is now gathering support around the previous resistance level. The stock has been in a steady accumulation stage with a strong uptrend and increasing volume. The strong uptrend should continue. The Benchmark Company has also changed their status from a Speculative Buy to a Buy, as of today. There is enough volume to identify a cup and handle pattern. You can also identify a rising triangle from point X to the support level forming line 1, and point B up to the current low price making up line 2. This is a continuation pattern, indicating the direction of the price movement should continue, which in the current stage is up. All these patterns indicate that HBIO is likely to have a bull run. The price target is $6, a 36% upside from the current price of 4.4